
<div>
  <div class="hero-banner">
    <div>
      <div>
        <picture>
          <source type="image/webp" srcset="./media_1845280d4f16197be6756006094a10358781baad7.png?width=2000&#x26;format=webply&#x26;optimize=medium" media="(min-width: 600px)">
          <source type="image/webp" srcset="./media_1845280d4f16197be6756006094a10358781baad7.png?width=750&#x26;format=webply&#x26;optimize=medium">
          <source type="image/png" srcset="./media_1845280d4f16197be6756006094a10358781baad7.png?width=2000&#x26;format=png&#x26;optimize=medium" media="(min-width: 600px)">
          <img loading="lazy" alt="" src="./media_1845280d4f16197be6756006094a10358781baad7.png?width=750&#x26;format=png&#x26;optimize=medium" width="3840" height="570">
        </picture>
      </div>
    </div>
    <div>
      <div>
        <h1 id="about-hyperkalemia">About Hyperkalemia</h1>
      </div>
    </div>
  </div>
</div>
<div>
  <h2 id="hyperkalemia-is-an-electrolyte-disorder1">Hyperkalemia is an electrolyte disorder<sup>1</sup></h2>
</div>
<div>
  <h3 id="predisposing-factors1-5">Predisposing factors:<sup>1-5</sup></h3>
  <div class="columns-factors">
    <div>
      <div>
        <p>
          <picture>
            <source type="image/webp" srcset="./media_165ef3bcc236d5282b833ad1bf82c2252a749a87a.png?width=2000&#x26;format=webply&#x26;optimize=medium" media="(min-width: 600px)">
            <source type="image/webp" srcset="./media_165ef3bcc236d5282b833ad1bf82c2252a749a87a.png?width=750&#x26;format=webply&#x26;optimize=medium">
            <source type="image/png" srcset="./media_165ef3bcc236d5282b833ad1bf82c2252a749a87a.png?width=2000&#x26;format=png&#x26;optimize=medium" media="(min-width: 600px)">
            <img loading="lazy" alt="" src="./media_165ef3bcc236d5282b833ad1bf82c2252a749a87a.png?width=750&#x26;format=png&#x26;optimize=medium" width="252" height="252">
          </picture>
        </p>
        <p><strong>HF</strong></p>
      </div>
      <div>
        <p>
          <picture>
            <source type="image/webp" srcset="./media_1d7c1571eed57fae7ac1095a08d34325ca6d111a6.png?width=2000&#x26;format=webply&#x26;optimize=medium" media="(min-width: 600px)">
            <source type="image/webp" srcset="./media_1d7c1571eed57fae7ac1095a08d34325ca6d111a6.png?width=750&#x26;format=webply&#x26;optimize=medium">
            <source type="image/png" srcset="./media_1d7c1571eed57fae7ac1095a08d34325ca6d111a6.png?width=2000&#x26;format=png&#x26;optimize=medium" media="(min-width: 600px)">
            <img loading="lazy" alt="" src="./media_1d7c1571eed57fae7ac1095a08d34325ca6d111a6.png?width=750&#x26;format=png&#x26;optimize=medium" width="252" height="252">
          </picture>
        </p>
        <p><strong>T2D</strong></p>
      </div>
      <div>
        <p>
          <picture>
            <source type="image/webp" srcset="./media_1c55e3d04cb95624e8f88c19f62cda0fb59fbe43a.png?width=2000&#x26;format=webply&#x26;optimize=medium" media="(min-width: 600px)">
            <source type="image/webp" srcset="./media_1c55e3d04cb95624e8f88c19f62cda0fb59fbe43a.png?width=750&#x26;format=webply&#x26;optimize=medium">
            <source type="image/png" srcset="./media_1c55e3d04cb95624e8f88c19f62cda0fb59fbe43a.png?width=2000&#x26;format=png&#x26;optimize=medium" media="(min-width: 600px)">
            <img loading="lazy" alt="" src="./media_1c55e3d04cb95624e8f88c19f62cda0fb59fbe43a.png?width=750&#x26;format=png&#x26;optimize=medium" width="252" height="252">
          </picture>
        </p>
        <p><strong>CKD</strong></p>
      </div>
      <div><strong>Concomitant RAASi use</strong></div>
    </div>
  </div>
</div>
<div>
  <p><strong>In studies, the incidence of hyperkalemia over follow-up duration of approximately 1 year was observed to be:6</strong></p>
</div>
<div>
  <div class="columns-statistics">
    <div>
      <div>
        <p>
          <img src="about:error" alt="Pie chart showing less than 5 percent" loading="lazy">
        </p>
        <p><strong>&#x3C;5%</strong></p>
        <p>with HF</p>
      </div>
      <div>
        <p>
          <img src="about:error" alt="Pie chart showing 40 percent" loading="lazy">
        </p>
        <p><strong>Up to 40%</strong></p>
        <p>with chronic HF</p>
      </div>
      <div>
        <p>
          <img src="about:error" alt="Pie chart showing approximately 73 percent" loading="lazy">
        </p>
        <p><strong>~73%</strong></p>
        <p>with CKD</p>
      </div>
    </div>
  </div>
</div>
<div>
  <div class="columns-callout">
    <div>
      <div>Diabetes Canada guidelines recommend sodium zirconium cyclosilicate as a treatment option in patients with moderate to high potassium<sup>1</sup></div>
    </div>
  </div>
</div>
<div>
  <div class="columns-callout">
    <div>
      <div>KDIGO guidelines recommend potassium binders as a treatment option for RAASi-induced hyperkalemia<sup>7*</sup></div>
    </div>
  </div>
</div>
<div>
  <p>* Practice points are consensus-based statements representing the expert judgment of the Work Group and are not graded. Although these statements are developed based on a different methodology, they should not be seen as "less important" or a "downgrade" from graded recommendations.<sup>7</sup></p>
  <p>CKD=chronic kidney disease; HF=heart failure; RAASi=Renin-angiotensin-aldosterone system inhibitor; T2D=Type 2 diabetes.</p>
</div>
<div>
  <h2 id="references">References</h2>
  <ol>
    <li>Tobe SW, et al. Chronic kidney disease in diabetes: A clinical practice guideline. <em>Can J Diabetes.</em> 2025;49:73-86.</li>
    <li>Kovesdy CP. Updates in hyperkalemia: Outcomes and therapeutic strategies. <em>Rev Endocr Metab Disord.</em> 2017;18(1):41-47.</li>
    <li>Michel A, et al. Risk factors for hyperkalemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice. <em>European Journal of Heart Failure.</em> 2015;17:205-213.</li>
    <li>Weir MR, et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. <em>N Engl J Med.</em> 2015;372:211-221.</li>
    <li>National Kidney Foundation. Clinical update on hyperkalemia. A chronic risk for CKD patients and a potential barrier to recommended CKD treatment. 2014. https://www.kidney.org/sites/default/files/02-10-6785_HBE_Hyperkalemia_Bulletin.pdf Accessed April 11, 2025.</li>
    <li>McDonagh TA, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. <em>Eur Heart J.</em> 2021 Sep 21;42(36):3599-3726.</li>
    <li>Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. <em>Kidney Int.</em> 2024;105(4S):S117-S314.</li>
  </ol>
</div>
